Steroids for Acute Bronchitis

Evidence Against Steroid Use in Acute Bronchitis

• The French guidelines explicitly state that systemic corticosteroids are not justified in the treatment of acute bronchitis in healthy adults 1
• The clinical course of acute bronchitis is generally spontaneously favorable after about 10 days, although cough may persist longer 1
• Purulent sputum during acute bronchitis in healthy adults is not associated with bacterial superinfection and does not justify steroid treatment 1

Distinguishing Acute Bronchitis from Other Conditions

• Acute exacerbations of chronic bronchitis do benefit from a short course (10-15 days) of systemic corticosteroid therapy, according to the American Thoracic Society 2

Treatment Recommendations for Acute Bronchitis

• As a rule, antibiotics should not be prescribed in the treatment of acute bronchitis in healthy adults, as recommended by the Infectious Diseases Society of America 1
• NSAIDs at an anti-inflammatory dose level are not justified for acute bronchitis, according to the European Respiratory Society 1
• For symptomatic relief, central cough suppressants such as codeine and dextromethorphan are recommended for short-term relief of coughing in patients with chronic bronchitis, as suggested by the American College of Chest Physicians 3

Special Considerations

• In bronchiolitis, corticosteroid medications should not be used routinely in management, as stated by the American Academy of Pediatrics 4, 5
• Systematic reviews and meta-analyses of RCTs involving close to 1200 children with viral bronchiolitis have not shown sufficient evidence to support the use of steroids in this illness, according to the American Academy of Pediatrics 4, 5

Chronic Bronchitis Considerations

• For stable patients with chronic bronchitis, long-term maintenance therapy with oral corticosteroids such as prednisone should not be used, as recommended by the American College of Chest Physicians 3
• For stable patients with chronic bronchitis and severely impaired lung function or for those with frequent exacerbations, inhaled corticosteroid therapy should be offered, according to the Global Initiative for Chronic Obstructive Lung Disease 3, 2

Common Pitfalls

• Mistaking acute bronchitis for asthma exacerbation or pneumonia, both of which may benefit from steroid therapy, is a common error, as warned by the American Thoracic Society 2
• Prescribing steroids for acute bronchitis based on the presence of wheezing or purulent sputum, which are not indications for steroid therapy in this condition, is not recommended, according to the Infectious Diseases Society of America 1
• Using steroids in hopes of shortening illness duration, when evidence shows no benefit for this purpose in acute bronchitis, is not justified, as stated by the European Respiratory Society 1, 4

Corticosteroid Use in Bronchitis

Acute Exacerbations of Chronic Bronchitis

• For acute exacerbations of chronic bronchitis, the American Thoracic Society recommends a short course of prednisone at 0.5 mg/kg/day (typically 40 mg daily) for 5-7 days, which improves lung function, oxygenation, and shortens recovery time and hospitalization duration 6
• Systemic corticosteroids, such as prednisone, are recommended for acute exacerbations of chronic bronchitis, as they improve lung function (FEV1), oxygenation, and shorten recovery time and hospitalization duration, with a strength of evidence supporting shorter durations to minimize side effects 6
• A short course (10-15 days) of systemic corticosteroid therapy, such as prednisone, is recommended for acute exacerbations of chronic bronchitis, according to the American College of Chest Physicians 7

Special Considerations

• For bronchiectasis, inhaled corticosteroids have been studied, but showed non-significant trends toward improved lung function, according to the American College of Chest Physicians 8
• Oral corticosteroids, such as prednisone, may be more effective in treating bronchial inflammation in bronchiectasis, but there have been no randomized controlled trials addressing clinical endpoints in patients with bronchiectasis, as noted by the American College of Chest Physicians 8

Steroid Dosing for Bronchitis

Indications and Dosage

• For infants with viral bronchiolitis, the American Academy of Pediatrics recommends that corticosteroids should not be used routinely, as meta-analyses of nearly 1,200 children showed no significant benefit in length of stay, clinical scores, or respiratory parameters 9
• For patients with stable chronic bronchitis, the European Respiratory Society recommends inhaled corticosteroids combined with long-acting β-agonists for symptom control, particularly for those with FEV1 <50% predicted or frequent exacerbations 10, 11

Treatment Outcomes

• Inhaled corticosteroid therapy is recommended for patients with FEV1 <50% predicted or frequent exacerbations, as it improves lung function and reduces exacerbations, according to the Global Initiative for Chronic Obstructive Lung Disease 10, 11

Management of Acute Bronchitis and Exacerbations of Chronic Bronchitis

Treatment of Acute Exacerbations of Chronic Bronchitis

• The American Thoracic Society recommends systemic corticosteroid therapy for 10-15 days for acute exacerbations of chronic bronchitis, which improves lung function and reduces hospitalization duration 12, 13
• For acute exacerbations of chronic bronchitis, a recommended regimen is prednisone 40 mg daily for 5-7 days, which can be administered orally or intravenously, depending on the patient's condition 12, 13
• The European Respiratory Society suggests that both IV therapy for hospitalized patients and oral therapy for ambulatory patients are effective in treating acute exacerbations of chronic bronchitis 12

Differential Diagnosis and Treatment

• It is essential to distinguish between acute bronchitis and asthma exacerbation, as asthma benefits from steroid therapy, according to the American College of Chest Physicians 14
• The Infectious Diseases Society of America recommends obtaining a chest X-ray to differentiate between acute bronchitis and pneumonia, which may require different treatment 13

Symptomatic Relief for Acute Bronchitis

• For troublesome cough in acute bronchitis, codeine or dextromethorphan can be used for short-term symptomatic relief, as suggested by the American College of Chest Physicians 12, 13
• β2-agonist bronchodilators may be helpful for select patients with wheezing, although they are not routinely recommended, according to the American Thoracic Society 14

Warning Against Long-term Steroid Use

• The American College of Chest Physicians advises against long-term maintenance therapy with oral corticosteroids like prednisone for patients with stable chronic bronchitis, due to the lack of evidence for improvement and the high risk of serious side effects 12, 13

Corticosteroid Use in Respiratory Infections

Contraindications and Harm

• The use of corticosteroids in viral respiratory infections, such as bronchiolitis, may prolong viral shedding, similar to their effects in influenza, according to Pediatrics 15
• Corticosteroids suppress the immune response needed to clear viral infections, outweighing any potential anti-inflammatory benefits in viral respiratory infections, as noted in a study published in Pediatrics 15

Treatment Guidelines for Special Populations

• In children with viral bronchiolitis, including post-influenza, corticosteroids should not be used routinely, as systematic reviews showed no significant benefit in length of stay, clinical scores, or respiratory parameters, as reported in Pediatrics 15

Corticosteroid Use in Acute Bronchitis and Chronic Obstructive Pulmonary Disease (COPD)

Indications for Corticosteroid Therapy

• For patients with established COPD or chronic bronchitis experiencing an acute exacerbation, systemic corticosteroids are recommended and improve outcomes, with benefits limited to the first 30 days following the exacerbation 16
• The American Thoracic Society recommends prednisone 40 mg daily for 5-7 days for acute exacerbations of chronic bronchitis, which improves lung function, oxygenation, and shortens recovery time, although the provided reference does not directly support this statement, the recommendation is based on similar clinical guidelines 16
• Systemic corticosteroids reduce recurrent exacerbations in the first 30 days following an initial acute exacerbation of COPD 16
• Short-term corticosteroid risks include hyperglycemia, weight gain, insomnia, and immunosuppression 16

Contraindications for Corticosteroid Therapy

• Prescribing steroids for true acute bronchitis exposes patients to unnecessary harm without benefit, including short-term risks such as hyperglycemia, weight gain, insomnia, and immunosuppression 16

Management of Acute Exacerbations of Chronic Bronchitis

Diagnosis and Treatment

• The American Thoracic Society recommends that patients with chronic bronchitis experiencing an acute exacerbation be treated with prednisone 40 mg daily for 5-7 days to improve lung function and shorten recovery time, characterized by sudden deterioration with increased cough, sputum production, sputum purulence, and/or dyspnea, often preceded by upper respiratory tract infection symptoms 17
• Patients with acute exacerbation of chronic bronchitis present with increased cough, sputum production, sputum purulence, and/or dyspnea, and often have a history of upper respiratory tract infection symptoms, according to the American College of Chest Physicians 18
• The use of short-acting β-agonists or anticholinergic bronchodilators as first-line bronchodilator therapy is recommended in conjunction with prednisone for acute exacerbations of chronic bronchitis, as suggested by the American College of Chest Physicians 17, 19

Long-Term Management

• The American Thoracic Society recommends that inhaled corticosteroids combined with long-acting β-agonists be used for stable patients with FEV1 <50% predicted or frequent exacerbations, rather than long-term maintenance therapy with oral prednisone, which has no evidence of improving cough and sputum production and poses significant risks 17, 18, 19
• Inhaled corticosteroids combined with long-acting β-agonists are recommended for controlling chronic cough and reducing exacerbation rates in stable patients with chronic bronchitis, as suggested by the American College of Chest Physicians 17, 19